ScoreWhy is Lipigon Pharmaceuticals AB ?
1
The company has declared Negative results for the last 3 consecutive quarters
- PRE-TAX PROFIT(Q) At SEK -9.15 MM has Fallen at -44.96%
- NET PROFIT(Q) At SEK -9.15 MM has Fallen at -44.96%
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -91.12%, its profits have fallen by -74.2%
3
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -91.12% returns in the last 1 year, the stock has also underperformed OMX Stockholm 30 in each of the last 3 annual periods
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Lipigon Pharmaceuticals AB for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Lipigon Pharmaceuticals AB
-100.0%
-0.64
147.86%
OMX Stockholm 30
8.45%
0.44
18.11%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-85.98%
EBIT Growth (5y)
14.44%
EBIT to Interest (avg)
-17.57
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.13
Sales to Capital Employed (avg)
0.58
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
3.67
EV to EBIT
-1.62
EV to EBITDA
-1.63
EV to Capital Employed
-22.70
EV to Sales
43.57
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-157.12%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Bearish
Bearish
OBV
Bearish
Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend7What is working for the Company
NET SALES(9M)
At SEK 1.32 MM has Grown at 269.19%
NET PROFIT(HY)
Higher at SEK -19.87 MM
RAW MATERIAL COST(Y)
Fallen by 0% (YoY
-11What is not working for the Company
PRE-TAX PROFIT(Q)
At SEK -9.15 MM has Fallen at -44.96%
NET PROFIT(Q)
At SEK -9.15 MM has Fallen at -44.96%
Here's what is working for Lipigon Pharmaceuticals AB
Net Sales
At SEK 1.32 MM has Grown at 269.19%
Year on Year (YoY)MOJO Watch
Sales trend is very positive
Net Sales (SEK MM)
Raw Material Cost
Fallen by 0% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Lipigon Pharmaceuticals AB
Pre-Tax Profit
At SEK -9.15 MM has Fallen at -44.96%
over average net sales of the previous four periods of SEK -6.32 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (SEK MM)
Net Profit
At SEK -9.15 MM has Fallen at -44.96%
over average net sales of the previous four periods of SEK -6.32 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (SEK MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
